2022
DOI: 10.1093/rheumatology/keac228
|View full text |Cite
|
Sign up to set email alerts
|

Controversies in rheumatology: ultrasound for monitoring of RA—do we need it?

Abstract: Clinical joint examination is the cornerstone for evaluation of patients with rheumatoid arthritis (RA). However, since large discrepancies have been shown even between experienced rheumatologists in evaluation of joint inflammation, and tender joints may have limited value in reflecting inflammation, ultrasound has in the last decennials been introduced in the clinical assessments of RA patients. Ultrasound has high accordance with other imaging modalities and enables detection of clinically difficult patholo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 55 publications
0
2
0
Order By: Relevance
“…Early symptoms of RA, such as joint pain, swelling, and stiffness, often lack speci city, resembling manifestations of other disorders, posing a potential challenge in the timely diagnosis and management of RA in its initial stages. Although imaging techniques like radiography, MRI and ultrasound technology are capable of assessing joint structure and pathology, their sensitivity in detecting early RA without evident bone damage is comparatively inadequate [22][23][24][25]. The most robust blood-based assays for RA currently heavily rely on serum protein biomarkers, with ACPA and RF being pivotal components of the standard RA classi cation criteria set forth by the American College of Rheumatology and the European League Against Rheumatism [26].…”
Section: Discussionmentioning
confidence: 99%
“…Early symptoms of RA, such as joint pain, swelling, and stiffness, often lack speci city, resembling manifestations of other disorders, posing a potential challenge in the timely diagnosis and management of RA in its initial stages. Although imaging techniques like radiography, MRI and ultrasound technology are capable of assessing joint structure and pathology, their sensitivity in detecting early RA without evident bone damage is comparatively inadequate [22][23][24][25]. The most robust blood-based assays for RA currently heavily rely on serum protein biomarkers, with ACPA and RF being pivotal components of the standard RA classi cation criteria set forth by the American College of Rheumatology and the European League Against Rheumatism [26].…”
Section: Discussionmentioning
confidence: 99%
“…9,10 Synovial features, without biopsy, utilizing power Doppler detecting red blood cell movement that can serve as a surrogate marker for the presence and intensity of synovitis, have been extensively studied 11 and proposed as an outcome measure for treatments of inflammatory arthropathies, although the utility of such techniques remains unsettled. 12 Media comprised tiny gas-filled microbubbles, injected intravenously before US examination, and enhanced the signal reflected by vascularized structures such as inflamed synovium. Such contrast-enhanced MSKUS examination detects synovitis with greater sensitivity and accuracy 13 but has not yet been adapted to the bedside.…”
Section: Ultrasoundmentioning
confidence: 99%